Levy Wealth Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.11M | Buy |
6,468
+16
| +0.2% | +$2.74K | 0.28% | 42 |
|
|
2024
Q1 | $1,000K | Hold |
6,452
| – | – | 0.28% | 39 |
|
|
2023
Q4 | $1,000K | Buy |
6,452
+10
| +0.2% | +$1.55K | 0.28% | 39 |
|
|
2023
Q3 | $960K | Buy |
6,442
+8
| +0.1% | +$1.19K | 0.3% | 40 |
|
|
2023
Q2 | $867K | Buy |
6,434
+9
| +0.1% | +$1.21K | 0.26% | 43 |
|
|
2023
Q1 | $1.02M | Buy |
6,425
+8
| +0.1% | +$1.28K | 0.32% | 38 |
|
|
2022
Q4 | $1.04M | Sell |
6,417
-129
| -2% | -$20.8K | 0.35% | 35 |
|
|
2022
Q3 | $879K | Buy |
6,546
+144
| +2% | +$19.3K | 0.38% | 30 |
|
|
2022
Q2 | $981K | Buy |
6,402
+7
| +0.1% | +$1.07K | 0.45% | 29 |
|
|
2022
Q1 | $1.04M | Buy |
6,395
+8
| +0.1% | +$1.3K | 0.43% | 28 |
|
|
2021
Q4 | $865K | Buy |
6,387
+9
| +0.1% | +$1.22K | 0.39% | 31 |
|
|
2021
Q3 | $688K | Buy |
6,378
+6
| +0.1% | +$647 | 0.38% | 32 |
|
|
2021
Q2 | $718K | Buy |
6,372
+14
| +0.2% | +$1.58K | 0.41% | 32 |
|
|
2021
Q1 | $688K | Buy |
6,358
+16
| +0.3% | +$1.73K | 0.45% | 31 |
|
|
2020
Q4 | $680K | Buy |
+6,342
| New | +$680K | 0.48% | 30 |
|